# Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis

> **NCT00004747** · PHASE2 · COMPLETED · sponsor: **National Center for Research Resources (NCRR)** · enrollment: 170 (—)

## Conditions studied

- Cystic Fibrosis
- Bacterial Infections

## Interventions

- **DRUG:** mucoid exopolysaccharide P. aeruginosa immune globulin IV

## Key facts

- **NCT ID:** NCT00004747
- **Lead sponsor:** National Center for Research Resources (NCRR)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 170 (—)
- **Last updated:** 2005-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004747, "Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00004747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*